1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Nutraceuticals CDMO Market
2.3. Global Nutraceuticals CDMO Market, By Dosage Forms, 2025 (US$ Million)
2.4. Global Nutraceuticals CDMO Market, By Services, 2025 (US$ Million)
2.5. Global Nutraceuticals CDMO Market, By Company Size, 2025 (US$ Million)
2.6. Global Nutraceuticals CDMO Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Nutraceuticals CDMO Market: Competitive Analysis
3.1. Market Positioning of Key Nutraceuticals CDMO Market Vendors
3.2. Strategies Adopted by Nutraceuticals CDMO Market Vendors
4. Nutraceuticals CDMO Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Nutraceuticals CDMO Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Tablets & Capsules
5.3.2. Powder
5.3.3. Softgel
5.3.4. Others
6. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Product Formulation and Development
6.3.2. Manufacturing and Packaging
6.3.3. Research and Development (R&D)
6.3.4. Regulatory Compliance
6.3.5. Others
7. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Small Companies
7.3.2. Mid-Sized Companies
7.3.3. Large Companies
8. North America Nutraceuticals CDMO Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
8.3. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
8.4. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
8.5. Nutraceuticals CDMO Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
8.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
8.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
8.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
8.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
8.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
8.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9. UK and European Union Nutraceuticals CDMO Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.3. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.4. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5. Nutraceuticals CDMO Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
9.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
9.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10. Asia Pacific Nutraceuticals CDMO Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.3. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.4. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5. Nutraceuticals CDMO Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
10.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
10.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
11. Latin America Nutraceuticals CDMO Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
11.3. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
11.4. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
11.5. Nutraceuticals CDMO Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
11.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
11.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
11.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
11.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
11.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
11.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
12. Middle East and Africa Nutraceuticals CDMO Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
12.3. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
12.4. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
12.5. Nutraceuticals CDMO Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
12.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
12.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
12.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
12.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2024-2034, USD (Million)
12.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2024-2034, USD (Million)
12.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2024-2034, USD (Million)
13. Company Profile
13.1. Catalent (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Lonza Group
13.3. Royal DSM
13.4. BASF
13.5. Kerry Group
13.6. Archer Daniels Midland
13.7. Glanbia
13.8. Capsugel
13.9. Aenova Group
13.10. NutraScience Labs
13.11. Nutragenesis
13.12. Pharmavite
13.13. SirioPharma
13.14. Balchem Corporation
13.15. SirioPharma International
13.16. Other Notable Players
